nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—systemic scleroderma—ankylosing spondylitis	0.961	1	CtDrD
Pentoxifylline—Discomfort—Prednisolone—ankylosing spondylitis	0.000144	0.0037	CcSEcCtD
Pentoxifylline—Angioedema—Triamcinolone—ankylosing spondylitis	0.000144	0.0037	CcSEcCtD
Pentoxifylline—Haemoglobin—Prednisone—ankylosing spondylitis	0.000143	0.00369	CcSEcCtD
Pentoxifylline—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000143	0.00369	CcSEcCtD
Pentoxifylline—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000143	0.00367	CcSEcCtD
Pentoxifylline—Haemorrhage—Prednisone—ankylosing spondylitis	0.000143	0.00367	CcSEcCtD
Pentoxifylline—Erythema—Dexamethasone—ankylosing spondylitis	0.000143	0.00367	CcSEcCtD
Pentoxifylline—Erythema—Betamethasone—ankylosing spondylitis	0.000143	0.00367	CcSEcCtD
Pentoxifylline—Malaise—Triamcinolone—ankylosing spondylitis	0.000142	0.00365	CcSEcCtD
Pentoxifylline—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000141	0.00364	CcSEcCtD
Pentoxifylline—Malaise—Methylprednisolone—ankylosing spondylitis	0.000141	0.00364	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000139	0.00359	CcSEcCtD
Pentoxifylline—Oedema—Prednisolone—ankylosing spondylitis	0.000139	0.00359	CcSEcCtD
Pentoxifylline—Shock—Prednisolone—ankylosing spondylitis	0.000137	0.00353	CcSEcCtD
Pentoxifylline—Convulsion—Triamcinolone—ankylosing spondylitis	0.000136	0.0035	CcSEcCtD
Pentoxifylline—Tachycardia—Prednisolone—ankylosing spondylitis	0.000136	0.0035	CcSEcCtD
Pentoxifylline—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000136	0.0035	CcSEcCtD
Pentoxifylline—Hypertension—Triamcinolone—ankylosing spondylitis	0.000136	0.00349	CcSEcCtD
Pentoxifylline—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000135	0.00348	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000135	0.00347	CcSEcCtD
Pentoxifylline—Myalgia—Triamcinolone—ankylosing spondylitis	0.000134	0.00344	CcSEcCtD
Pentoxifylline—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000134	0.00344	CcSEcCtD
Pentoxifylline—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000133	0.00342	CcSEcCtD
Pentoxifylline—Drowsiness—Methotrexate—ankylosing spondylitis	0.000133	0.00342	CcSEcCtD
Pentoxifylline—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000133	0.00342	CcSEcCtD
Pentoxifylline—Infestation—Methotrexate—ankylosing spondylitis	0.000133	0.00342	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000133	0.00341	CcSEcCtD
Pentoxifylline—Flushing—Prednisone—ankylosing spondylitis	0.000132	0.00341	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000132	0.00341	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000132	0.00341	CcSEcCtD
Pentoxifylline—Discomfort—Triamcinolone—ankylosing spondylitis	0.000132	0.0034	CcSEcCtD
Pentoxifylline—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000132	0.00339	CcSEcCtD
Pentoxifylline—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000131	0.00337	CcSEcCtD
Pentoxifylline—Angioedema—Betamethasone—ankylosing spondylitis	0.00013	0.00335	CcSEcCtD
Pentoxifylline—Angioedema—Dexamethasone—ankylosing spondylitis	0.00013	0.00335	CcSEcCtD
Pentoxifylline—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000129	0.00332	CcSEcCtD
Pentoxifylline—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000129	0.00332	CcSEcCtD
Pentoxifylline—Immune system disorder—Prednisone—ankylosing spondylitis	0.000129	0.00332	CcSEcCtD
Pentoxifylline—Malaise—Dexamethasone—ankylosing spondylitis	0.000129	0.00331	CcSEcCtD
Pentoxifylline—Malaise—Betamethasone—ankylosing spondylitis	0.000129	0.00331	CcSEcCtD
Pentoxifylline—Oedema—Triamcinolone—ankylosing spondylitis	0.000128	0.0033	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000128	0.0033	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000128	0.00329	CcSEcCtD
Pentoxifylline—Arrhythmia—Prednisone—ankylosing spondylitis	0.000127	0.00328	CcSEcCtD
Pentoxifylline—Infection—Triamcinolone—ankylosing spondylitis	0.000127	0.00328	CcSEcCtD
Pentoxifylline—Sweating—Methotrexate—ankylosing spondylitis	0.000127	0.00328	CcSEcCtD
Pentoxifylline—Infection—Methylprednisolone—ankylosing spondylitis	0.000127	0.00327	CcSEcCtD
Pentoxifylline—Shock—Triamcinolone—ankylosing spondylitis	0.000126	0.00325	CcSEcCtD
Pentoxifylline—Insomnia—Prednisolone—ankylosing spondylitis	0.000126	0.00325	CcSEcCtD
Pentoxifylline—Shock—Methylprednisolone—ankylosing spondylitis	0.000126	0.00324	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000126	0.00323	CcSEcCtD
Pentoxifylline—Epistaxis—Methotrexate—ankylosing spondylitis	0.000125	0.00322	CcSEcCtD
Pentoxifylline—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000125	0.00322	CcSEcCtD
Pentoxifylline—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000125	0.00321	CcSEcCtD
Pentoxifylline—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000124	0.0032	CcSEcCtD
Pentoxifylline—Erythema—Prednisone—ankylosing spondylitis	0.000124	0.0032	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000124	0.00319	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000124	0.00318	CcSEcCtD
Pentoxifylline—Convulsion—Dexamethasone—ankylosing spondylitis	0.000124	0.00318	CcSEcCtD
Pentoxifylline—Convulsion—Betamethasone—ankylosing spondylitis	0.000124	0.00318	CcSEcCtD
Pentoxifylline—Hypertension—Betamethasone—ankylosing spondylitis	0.000123	0.00317	CcSEcCtD
Pentoxifylline—Hypertension—Dexamethasone—ankylosing spondylitis	0.000123	0.00317	CcSEcCtD
Pentoxifylline—Myalgia—Betamethasone—ankylosing spondylitis	0.000121	0.00312	CcSEcCtD
Pentoxifylline—Myalgia—Dexamethasone—ankylosing spondylitis	0.000121	0.00312	CcSEcCtD
Pentoxifylline—Anxiety—Dexamethasone—ankylosing spondylitis	0.000121	0.00311	CcSEcCtD
Pentoxifylline—Anxiety—Betamethasone—ankylosing spondylitis	0.000121	0.00311	CcSEcCtD
Pentoxifylline—Discomfort—Betamethasone—ankylosing spondylitis	0.00012	0.00309	CcSEcCtD
Pentoxifylline—Discomfort—Dexamethasone—ankylosing spondylitis	0.00012	0.00309	CcSEcCtD
Pentoxifylline—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00012	0.00308	CcSEcCtD
Pentoxifylline—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00012	0.00308	CcSEcCtD
Pentoxifylline—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000119	0.00307	CcSEcCtD
Pentoxifylline—Hepatitis—Methotrexate—ankylosing spondylitis	0.000119	0.00307	CcSEcCtD
Pentoxifylline—Vision blurred—Prednisone—ankylosing spondylitis	0.000117	0.00301	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000117	0.00301	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000117	0.003	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000116	0.003	CcSEcCtD
Pentoxifylline—Oedema—Betamethasone—ankylosing spondylitis	0.000116	0.003	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000116	0.003	CcSEcCtD
Pentoxifylline—Oedema—Dexamethasone—ankylosing spondylitis	0.000116	0.003	CcSEcCtD
Pentoxifylline—Insomnia—Triamcinolone—ankylosing spondylitis	0.000116	0.00299	CcSEcCtD
Pentoxifylline—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000116	0.00298	CcSEcCtD
Pentoxifylline—Infection—Betamethasone—ankylosing spondylitis	0.000116	0.00298	CcSEcCtD
Pentoxifylline—Infection—Dexamethasone—ankylosing spondylitis	0.000116	0.00298	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000115	0.00297	CcSEcCtD
Pentoxifylline—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000115	0.00296	CcSEcCtD
Pentoxifylline—Anaemia—Prednisone—ankylosing spondylitis	0.000115	0.00295	CcSEcCtD
Pentoxifylline—Shock—Dexamethasone—ankylosing spondylitis	0.000115	0.00295	CcSEcCtD
Pentoxifylline—Shock—Betamethasone—ankylosing spondylitis	0.000115	0.00295	CcSEcCtD
Pentoxifylline—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000114	0.00294	CcSEcCtD
Pentoxifylline—Agitation—Prednisone—ankylosing spondylitis	0.000114	0.00294	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000114	0.00293	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000114	0.00293	CcSEcCtD
Pentoxifylline—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000114	0.00292	CcSEcCtD
Pentoxifylline—Tachycardia—Betamethasone—ankylosing spondylitis	0.000114	0.00292	CcSEcCtD
Pentoxifylline—Angioedema—Prednisone—ankylosing spondylitis	0.000113	0.00292	CcSEcCtD
Pentoxifylline—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000113	0.00291	CcSEcCtD
Pentoxifylline—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000113	0.0029	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000113	0.0029	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000113	0.0029	CcSEcCtD
Pentoxifylline—Malaise—Prednisone—ankylosing spondylitis	0.000112	0.00288	CcSEcCtD
Pentoxifylline—Anorexia—Dexamethasone—ankylosing spondylitis	0.000111	0.00285	CcSEcCtD
Pentoxifylline—Anorexia—Betamethasone—ankylosing spondylitis	0.000111	0.00285	CcSEcCtD
Pentoxifylline—Urticaria—Prednisolone—ankylosing spondylitis	0.000111	0.00285	CcSEcCtD
Pentoxifylline—Hypotension—Dexamethasone—ankylosing spondylitis	0.000109	0.0028	CcSEcCtD
Pentoxifylline—Hypotension—Betamethasone—ankylosing spondylitis	0.000109	0.0028	CcSEcCtD
Pentoxifylline—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000108	0.00277	CcSEcCtD
Pentoxifylline—Convulsion—Prednisone—ankylosing spondylitis	0.000108	0.00277	CcSEcCtD
Pentoxifylline—Hypertension—Prednisone—ankylosing spondylitis	0.000107	0.00276	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000106	0.00273	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000106	0.00273	CcSEcCtD
Pentoxifylline—Myalgia—Prednisone—ankylosing spondylitis	0.000106	0.00272	CcSEcCtD
Pentoxifylline—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000106	0.00272	CcSEcCtD
Pentoxifylline—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000105	0.00271	CcSEcCtD
Pentoxifylline—Anxiety—Prednisone—ankylosing spondylitis	0.000105	0.00271	CcSEcCtD
Pentoxifylline—Insomnia—Betamethasone—ankylosing spondylitis	0.000105	0.00271	CcSEcCtD
Pentoxifylline—Insomnia—Dexamethasone—ankylosing spondylitis	0.000105	0.00271	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000105	0.0027	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000105	0.00269	CcSEcCtD
Pentoxifylline—Discomfort—Prednisone—ankylosing spondylitis	0.000104	0.00269	CcSEcCtD
Pentoxifylline—Erythema—Methotrexate—ankylosing spondylitis	0.000104	0.00267	CcSEcCtD
Pentoxifylline—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000103	0.00264	CcSEcCtD
Pentoxifylline—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000102	0.00264	CcSEcCtD
Pentoxifylline—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000102	0.00264	CcSEcCtD
Pentoxifylline—Urticaria—Triamcinolone—ankylosing spondylitis	0.000102	0.00262	CcSEcCtD
Pentoxifylline—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000102	0.00262	CcSEcCtD
Pentoxifylline—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000102	0.00262	CcSEcCtD
Pentoxifylline—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000101	0.00261	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000101	0.00261	CcSEcCtD
Pentoxifylline—Oedema—Prednisone—ankylosing spondylitis	0.000101	0.00261	CcSEcCtD
Pentoxifylline—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000101	0.0026	CcSEcCtD
Pentoxifylline—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000101	0.0026	CcSEcCtD
Pentoxifylline—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000101	0.0026	CcSEcCtD
Pentoxifylline—Infection—Prednisone—ankylosing spondylitis	0.000101	0.00259	CcSEcCtD
Pentoxifylline—Back pain—Methotrexate—ankylosing spondylitis	0.0001	0.00258	CcSEcCtD
Pentoxifylline—Shock—Prednisone—ankylosing spondylitis	9.97e-05	0.00257	CcSEcCtD
Pentoxifylline—Tachycardia—Prednisone—ankylosing spondylitis	9.89e-05	0.00255	CcSEcCtD
Pentoxifylline—Skin disorder—Prednisone—ankylosing spondylitis	9.85e-05	0.00253	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Prednisone—ankylosing spondylitis	9.8e-05	0.00252	CcSEcCtD
Pentoxifylline—Vision blurred—Methotrexate—ankylosing spondylitis	9.78e-05	0.00252	CcSEcCtD
Pentoxifylline—Anorexia—Prednisone—ankylosing spondylitis	9.66e-05	0.00249	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Methotrexate—ankylosing spondylitis	9.63e-05	0.00248	CcSEcCtD
Pentoxifylline—Anaemia—Methotrexate—ankylosing spondylitis	9.59e-05	0.00247	CcSEcCtD
Pentoxifylline—Feeling abnormal—Dexamethasone—ankylosing spondylitis	9.59e-05	0.00247	CcSEcCtD
Pentoxifylline—Feeling abnormal—Betamethasone—ankylosing spondylitis	9.59e-05	0.00247	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	9.52e-05	0.00245	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	9.52e-05	0.00245	CcSEcCtD
Pentoxifylline—Hypersensitivity—Triamcinolone—ankylosing spondylitis	9.45e-05	0.00243	CcSEcCtD
Pentoxifylline—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	9.43e-05	0.00243	CcSEcCtD
Pentoxifylline—Malaise—Methotrexate—ankylosing spondylitis	9.36e-05	0.00241	CcSEcCtD
Pentoxifylline—Leukopenia—Methotrexate—ankylosing spondylitis	9.29e-05	0.00239	CcSEcCtD
Pentoxifylline—Urticaria—Betamethasone—ankylosing spondylitis	9.25e-05	0.00238	CcSEcCtD
Pentoxifylline—Urticaria—Dexamethasone—ankylosing spondylitis	9.25e-05	0.00238	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	9.24e-05	0.00238	CcSEcCtD
Pentoxifylline—Dizziness—Prednisolone—ankylosing spondylitis	9.22e-05	0.00237	CcSEcCtD
Pentoxifylline—Asthenia—Triamcinolone—ankylosing spondylitis	9.2e-05	0.00237	CcSEcCtD
Pentoxifylline—Body temperature increased—Betamethasone—ankylosing spondylitis	9.2e-05	0.00237	CcSEcCtD
Pentoxifylline—Body temperature increased—Dexamethasone—ankylosing spondylitis	9.2e-05	0.00237	CcSEcCtD
Pentoxifylline—Abdominal pain—Dexamethasone—ankylosing spondylitis	9.2e-05	0.00237	CcSEcCtD
Pentoxifylline—Abdominal pain—Betamethasone—ankylosing spondylitis	9.2e-05	0.00237	CcSEcCtD
Pentoxifylline—Asthenia—Methylprednisolone—ankylosing spondylitis	9.18e-05	0.00236	CcSEcCtD
Pentoxifylline—Insomnia—Prednisone—ankylosing spondylitis	9.17e-05	0.00236	CcSEcCtD
Pentoxifylline—Pruritus—Triamcinolone—ankylosing spondylitis	9.08e-05	0.00234	CcSEcCtD
Pentoxifylline—Pruritus—Methylprednisolone—ankylosing spondylitis	9.06e-05	0.00233	CcSEcCtD
Pentoxifylline—Convulsion—Methotrexate—ankylosing spondylitis	8.99e-05	0.00231	CcSEcCtD
Pentoxifylline—Dyspepsia—Prednisone—ankylosing spondylitis	8.92e-05	0.0023	CcSEcCtD
Pentoxifylline—Chest pain—Methotrexate—ankylosing spondylitis	8.84e-05	0.00227	CcSEcCtD
Pentoxifylline—Myalgia—Methotrexate—ankylosing spondylitis	8.84e-05	0.00227	CcSEcCtD
Pentoxifylline—Decreased appetite—Prednisone—ankylosing spondylitis	8.81e-05	0.00227	CcSEcCtD
Pentoxifylline—Rash—Prednisolone—ankylosing spondylitis	8.8e-05	0.00226	CcSEcCtD
Pentoxifylline—Dermatitis—Prednisolone—ankylosing spondylitis	8.79e-05	0.00226	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	8.78e-05	0.00226	CcSEcCtD
Pentoxifylline—Diarrhoea—Methylprednisolone—ankylosing spondylitis	8.76e-05	0.00225	CcSEcCtD
Pentoxifylline—Headache—Prednisolone—ankylosing spondylitis	8.74e-05	0.00225	CcSEcCtD
Pentoxifylline—Discomfort—Methotrexate—ankylosing spondylitis	8.73e-05	0.00225	CcSEcCtD
Pentoxifylline—Constipation—Prednisone—ankylosing spondylitis	8.67e-05	0.00223	CcSEcCtD
Pentoxifylline—Confusional state—Methotrexate—ankylosing spondylitis	8.54e-05	0.0022	CcSEcCtD
Pentoxifylline—Dizziness—Triamcinolone—ankylosing spondylitis	8.48e-05	0.00218	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Methotrexate—ankylosing spondylitis	8.47e-05	0.00218	CcSEcCtD
Pentoxifylline—Dizziness—Methylprednisolone—ankylosing spondylitis	8.46e-05	0.00218	CcSEcCtD
Pentoxifylline—Infection—Methotrexate—ankylosing spondylitis	8.42e-05	0.00217	CcSEcCtD
Pentoxifylline—Feeling abnormal—Prednisone—ankylosing spondylitis	8.35e-05	0.00215	CcSEcCtD
Pentoxifylline—Asthenia—Betamethasone—ankylosing spondylitis	8.35e-05	0.00215	CcSEcCtD
Pentoxifylline—Asthenia—Dexamethasone—ankylosing spondylitis	8.35e-05	0.00215	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Methotrexate—ankylosing spondylitis	8.29e-05	0.00213	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Prednisone—ankylosing spondylitis	8.29e-05	0.00213	CcSEcCtD
Pentoxifylline—Nausea—Prednisolone—ankylosing spondylitis	8.29e-05	0.00213	CcSEcCtD
Pentoxifylline—Pruritus—Betamethasone—ankylosing spondylitis	8.24e-05	0.00212	CcSEcCtD
Pentoxifylline—Pruritus—Dexamethasone—ankylosing spondylitis	8.24e-05	0.00212	CcSEcCtD
Pentoxifylline—Skin disorder—Methotrexate—ankylosing spondylitis	8.23e-05	0.00212	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Methotrexate—ankylosing spondylitis	8.19e-05	0.00211	CcSEcCtD
Pentoxifylline—Vomiting—Triamcinolone—ankylosing spondylitis	8.16e-05	0.0021	CcSEcCtD
Pentoxifylline—Vomiting—Methylprednisolone—ankylosing spondylitis	8.14e-05	0.00209	CcSEcCtD
Pentoxifylline—Rash—Triamcinolone—ankylosing spondylitis	8.09e-05	0.00208	CcSEcCtD
Pentoxifylline—Dermatitis—Triamcinolone—ankylosing spondylitis	8.08e-05	0.00208	CcSEcCtD
Pentoxifylline—Anorexia—Methotrexate—ankylosing spondylitis	8.08e-05	0.00208	CcSEcCtD
Pentoxifylline—Rash—Methylprednisolone—ankylosing spondylitis	8.07e-05	0.00208	CcSEcCtD
Pentoxifylline—Dermatitis—Methylprednisolone—ankylosing spondylitis	8.06e-05	0.00207	CcSEcCtD
Pentoxifylline—Urticaria—Prednisone—ankylosing spondylitis	8.05e-05	0.00207	CcSEcCtD
Pentoxifylline—Headache—Triamcinolone—ankylosing spondylitis	8.04e-05	0.00207	CcSEcCtD
Pentoxifylline—Headache—Methylprednisolone—ankylosing spondylitis	8.02e-05	0.00206	CcSEcCtD
Pentoxifylline—Body temperature increased—Prednisone—ankylosing spondylitis	8.01e-05	0.00206	CcSEcCtD
Pentoxifylline—Abdominal pain—Prednisone—ankylosing spondylitis	8.01e-05	0.00206	CcSEcCtD
Pentoxifylline—Diarrhoea—Dexamethasone—ankylosing spondylitis	7.96e-05	0.00205	CcSEcCtD
Pentoxifylline—Diarrhoea—Betamethasone—ankylosing spondylitis	7.96e-05	0.00205	CcSEcCtD
Pentoxifylline—Hypotension—Methotrexate—ankylosing spondylitis	7.92e-05	0.00204	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	7.72e-05	0.00199	CcSEcCtD
Pentoxifylline—Dizziness—Betamethasone—ankylosing spondylitis	7.7e-05	0.00198	CcSEcCtD
Pentoxifylline—Dizziness—Dexamethasone—ankylosing spondylitis	7.7e-05	0.00198	CcSEcCtD
Pentoxifylline—Insomnia—Methotrexate—ankylosing spondylitis	7.66e-05	0.00197	CcSEcCtD
Pentoxifylline—Nausea—Triamcinolone—ankylosing spondylitis	7.62e-05	0.00196	CcSEcCtD
Pentoxifylline—Nausea—Methylprednisolone—ankylosing spondylitis	7.6e-05	0.00196	CcSEcCtD
Pentoxifylline—Dyspnoea—Methotrexate—ankylosing spondylitis	7.55e-05	0.00194	CcSEcCtD
Pentoxifylline—Somnolence—Methotrexate—ankylosing spondylitis	7.53e-05	0.00194	CcSEcCtD
Pentoxifylline—Hypersensitivity—Prednisone—ankylosing spondylitis	7.47e-05	0.00192	CcSEcCtD
Pentoxifylline—Dyspepsia—Methotrexate—ankylosing spondylitis	7.46e-05	0.00192	CcSEcCtD
Pentoxifylline—Vomiting—Betamethasone—ankylosing spondylitis	7.4e-05	0.0019	CcSEcCtD
Pentoxifylline—Vomiting—Dexamethasone—ankylosing spondylitis	7.4e-05	0.0019	CcSEcCtD
Pentoxifylline—Decreased appetite—Methotrexate—ankylosing spondylitis	7.36e-05	0.00189	CcSEcCtD
Pentoxifylline—Rash—Dexamethasone—ankylosing spondylitis	7.34e-05	0.00189	CcSEcCtD
Pentoxifylline—Rash—Betamethasone—ankylosing spondylitis	7.34e-05	0.00189	CcSEcCtD
Pentoxifylline—Dermatitis—Dexamethasone—ankylosing spondylitis	7.33e-05	0.00189	CcSEcCtD
Pentoxifylline—Dermatitis—Betamethasone—ankylosing spondylitis	7.33e-05	0.00189	CcSEcCtD
Pentoxifylline—Headache—Betamethasone—ankylosing spondylitis	7.29e-05	0.00188	CcSEcCtD
Pentoxifylline—Headache—Dexamethasone—ankylosing spondylitis	7.29e-05	0.00188	CcSEcCtD
Pentoxifylline—Asthenia—Prednisone—ankylosing spondylitis	7.27e-05	0.00187	CcSEcCtD
Pentoxifylline—Pruritus—Prednisone—ankylosing spondylitis	7.17e-05	0.00185	CcSEcCtD
Pentoxifylline—Feeling abnormal—Methotrexate—ankylosing spondylitis	6.98e-05	0.0018	CcSEcCtD
Pentoxifylline—Diarrhoea—Prednisone—ankylosing spondylitis	6.94e-05	0.00178	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	6.93e-05	0.00178	CcSEcCtD
Pentoxifylline—Nausea—Betamethasone—ankylosing spondylitis	6.91e-05	0.00178	CcSEcCtD
Pentoxifylline—Nausea—Dexamethasone—ankylosing spondylitis	6.91e-05	0.00178	CcSEcCtD
Pentoxifylline—Urticaria—Methotrexate—ankylosing spondylitis	6.73e-05	0.00173	CcSEcCtD
Pentoxifylline—Dizziness—Prednisone—ankylosing spondylitis	6.7e-05	0.00172	CcSEcCtD
Pentoxifylline—Abdominal pain—Methotrexate—ankylosing spondylitis	6.7e-05	0.00172	CcSEcCtD
Pentoxifylline—Body temperature increased—Methotrexate—ankylosing spondylitis	6.7e-05	0.00172	CcSEcCtD
Pentoxifylline—Vomiting—Prednisone—ankylosing spondylitis	6.45e-05	0.00166	CcSEcCtD
Pentoxifylline—Rash—Prednisone—ankylosing spondylitis	6.39e-05	0.00164	CcSEcCtD
Pentoxifylline—Dermatitis—Prednisone—ankylosing spondylitis	6.39e-05	0.00164	CcSEcCtD
Pentoxifylline—Headache—Prednisone—ankylosing spondylitis	6.35e-05	0.00163	CcSEcCtD
Pentoxifylline—Hypersensitivity—Methotrexate—ankylosing spondylitis	6.24e-05	0.00161	CcSEcCtD
Pentoxifylline—Asthenia—Methotrexate—ankylosing spondylitis	6.08e-05	0.00156	CcSEcCtD
Pentoxifylline—Nausea—Prednisone—ankylosing spondylitis	6.02e-05	0.00155	CcSEcCtD
Pentoxifylline—Pruritus—Methotrexate—ankylosing spondylitis	5.99e-05	0.00154	CcSEcCtD
Pentoxifylline—Diarrhoea—Methotrexate—ankylosing spondylitis	5.8e-05	0.00149	CcSEcCtD
Pentoxifylline—Dizziness—Methotrexate—ankylosing spondylitis	5.6e-05	0.00144	CcSEcCtD
Pentoxifylline—Vomiting—Methotrexate—ankylosing spondylitis	5.39e-05	0.00139	CcSEcCtD
Pentoxifylline—Rash—Methotrexate—ankylosing spondylitis	5.34e-05	0.00137	CcSEcCtD
Pentoxifylline—Dermatitis—Methotrexate—ankylosing spondylitis	5.34e-05	0.00137	CcSEcCtD
Pentoxifylline—Headache—Methotrexate—ankylosing spondylitis	5.31e-05	0.00137	CcSEcCtD
Pentoxifylline—Nausea—Methotrexate—ankylosing spondylitis	5.03e-05	0.00129	CcSEcCtD
